ghadmin
Guardant Health Appoints Myrtle Potter to Its Board of Directors
REDWOOD CITY, Calif.–(BUSINESS WIRE)– Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has appointed Myrtle Potter to serve on its Board of Directors.
Guardant Health Initiates ORACLE Study to Evaluate Performance of Guardant Reveal™ Blood Test to Predict Recurrence Across Early-Stage Cancers
1,000-patient prospective study in 11 solid tumors will monitor ctDNA levels up to five years
Craig Eagle of Guardant Health: In Light Of The Pandemic, Here Are The 5 Things We Need To Do To Improve The US Healthcare System
Place greater focus on healthcare equity — COVID-19 was a reminder of how disease disproportionately impacts certain groups, including people of color and lower socioeconomic status. Unfortunately, cancer, which remains a leading killer of Americans, is no different. We must continue to promote more equitable access to healthcare and the latest advancements, including easier-to-perform tests like liquid biopsy, to help democratize cancer testing and make the best treatments accessible to all people.
Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021
Guardant Health Reports Third Quarter 2021 Financial Results
Achieved record revenue of $94.8 million, Growth of 35% and 58% year over year in clinical and biopharma volumes, respectively
Doctors Predict Post-Pandemic Spike in Advanced Cancers: It’s Time to Adopt New Life-Saving…
At the onset of COVID-19, stay-at-home orders were necessary to address an acute public health problem. But the shutdowns had unintended consequences across other areas of healthcare.
The Top 50 Healthcare Technology CEOs Of 2021
The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2021. This year’s awardees represent some of the most accomplished executives in healthcare technology.
Discussing the Pivotal Role Biomarker Testing Plays in Treatment of Lung Cancer Patients
Worldwide, lung cancer is the leading cause of cancer death,1 and in the U.S., more than 235,000 people will be diagnosed with lung cancer this year.2 Non-small cell lung cancer (NSCLC) is a devastating disease that accounts for 84% of all lung cancer diagnoses.2
Catching cancer extremely early
Better, faster, and earlier: Cancer screening has come of age, with many methods capable of testing multiple cancers in one sample.
We Must Implement Covid Relief Because Cancer Doesn’t Wait
Two weeks ago, I was proud to join more than 150 business leaders in signing a letter urging Congress to swiftly adopt a COVID-19 stimulus and relief plan. Today, I am thrilled that the American Rescue Plan has been signed into law by President Joe Biden. This relief package is a significant and necessary step in the fight against COVID that will invigorate the public health response to the crisis and support desperately needed vaccination efforts.